Unexpected hair regrowth in a woman with longstanding Alopecia universalis [PDF]
GMS Ophthalmology Cases, 2021 Alopecia areata (AA) is an autoimmune disorder leading to non-scarring hair loss. As long as hair follicles are not destroyed, the potential for hair regrowth remains.
Akritidou, Fani +4 more
doaj +3 more sources
Successful treatment of alopecia universalis with abrocitinib: a case report
Journal of Dermatological Treatment, 2023 Abrocitinib, a highly selective inhibitor of Janus kinase 1 (JAK1), has been approved for the treatment of moderate-to-severe atopic dermatitis (AD).
Ya-Gang Zuo
exaly +3 more sources
Schizophrenia in a case of alopecia universalis
Annals of Indian Psychiatry, 2017 Alopecia universalis is characterized by total loss of hair from all over the body such as the scalp, eyebrows, and limbs. Alopecia areata has been known to coexist with psychiatric disorders such as anxiety disorders and depression, although reports ...
Deepa Sangolkar +4 more
doaj +2 more sources
Alopecia universalis, renal stones, and hyperuricemia: A familial or an unfamiliar association
Journal of Family Medicine and Primary Care, 2014 Alopecia Universalis is an autoimmune disorder which sometimes may be associated with other autoimmune diseases like vitiligo, atopic dermatitis and endocrine disorders like hypothyroidism.
Kalachand Jana +4 more
doaj +2 more sources
Drug Reaction with eosinophilia and systemic symptoms with alopecia universalis and vitiligo [PDF]
Medicina, 2021 Drug reactions with eosinophilia and systemic symptoms (DRESS) are rare and potentially fatal adverse hypersensitivity reaction to some drugs, especially anticonvulsants. The syndrome affects not only the skin but also other organs, especially the liver.
Ives Alexandre Yutani Koseki +5 more
doaj +2 more sources
Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient [PDF]
Journal of Allergy and Clinical Immunology: GlobalA 29-year-old male patient had severe atopic dermatitis (AD) and alopecia universalis (AU) that could not be controlled by using classic therapy. He started taking upadacitinib and achieved an excellent response for both his AD and AU. Thus, upadacitinib
Mara Giavina-Bianchi, MD, PhD +1 more
doaj +2 more sources
Diphenylcyclopropenone-Induced Vitiligo in a Patient with Alopecia Universalis
Case Reports in Dermatology, 2013 Alopecia areata and vitiligo are autoimmune diseases, both associated with multiple autoimmune comorbidities. Many studies show colocalization of these diseases at the same anatomical site.
Hassan Riad +6 more
doaj +2 more sources
Successful Therapy of Alopecia Universalis Using a Combination of Systemic Methotrexate and Corticosteroids and Topical 5% Minoxidil [PDF]
Clinical, Cosmetic and Investigational Dermatology, 2022 Kartika Ruchiatan, Erda Avriyanti, Reti Hindritiani, Diah Puspitosari, Oki Suwarsa, Hendra Gunawan Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran - Dr.
Ruchiatan K +5 more
doaj +2 more sources
Hairless Gene Nonsense Mutations in Alopecia Universalis: A Case Report [PDF]
Iranian Journal of Public Health, 2021 Alopecia universalis (AU) congenital, known as generalized atrichia, is a severe form of autosomal recessive alopecia that results in complete hair loss of scalp and body. Mutations in the human hairless gene (HR) are associated with the phenotype of the
Hamed Heidary +4 more
doaj +2 more sources
Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecial Totalis and Alopecia Universalis: A Randomized, Double-Blind, Placebo-Controlled Trial [PDF]
Siriraj Medical Journal, 2017 Background: Alopecia totalis (AT) and alopecia universalis (AU) have a high rate of recurrence and are very difficult to treat. To date, no consensus has been reach among clinicians regarding the best way to treat these conditions.
Rattapon Thuangtong +5 more
doaj +4 more sources